Kaposi's sarcoma:

Indications for: PANRETIN

Cutaneous lesions of AIDS-related Kaposi's sarcoma (KS).

Adult Dosage:

Apply twice daily to lesions (avoid mucous membranes and normal skin); do not occlude; may increase to 3–4 times daily as tolerated. Reduce frequency or suspend treatment if local toxicity occurs.

Children Dosage:

Not recommended.

PANRETIN Warnings/Precautions:

Not for use when systemic KS therapy required. Avoid sun, UV light. Flammable. Pregnancy (Cat.D), nursing mothers: not recommended.

PANRETIN Classification:


PANRETIN Interactions:

Increases DEET toxicity (avoid).

Adverse Reactions:

Photosensitivity, rash, pruritus, pain, exfoliative dermatitis, paresthesia, edema.

How Supplied: